ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

SGHT Sight Sciences Inc

5.48
-0.11 (-1.97%)
Last Updated: 09:01:17
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2,148
Bid Price 5.41
Ask Price 5.55
News -
Day High 5.97

Low
1.04

52 Week Range

High
11.01

Day Low 5.48
Share Name Share Symbol Market Stock Type
Sight Sciences Inc SGHT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.11 -1.97% 5.48 09:01:17
Open Price Low Price High Price Close Price Previous Close
5.62 5.48 5.97 5.59
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
51 2,148 US$ 5.58 US$ 11,981 - 1.04 - 11.01
Last Trade Type Quantity Price Currency
09:01:55 100 US$ 5.48 USD

Sight Sciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
271.55M 49.55M - 81.06M -55.55M -1.12 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Sight Sciences News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SGHT Message Board. Create One! See More Posts on SGHT Message Board See More Message Board Posts

Historical SGHT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.626.335.045.55190,832-0.14-2.49%
1 Month5.276.34255.005.60173,3840.213.98%
3 Months4.326.34254.015.01170,1001.1626.85%
6 Months1.586.34251.554.47371,3263.90246.84%
1 Year10.4511.011.044.41310,051-4.97-47.56%
3 Years30.0042.571.0411.38268,426-24.52-81.73%
5 Years30.0042.571.0411.38268,426-24.52-81.73%

Sight Sciences Description

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Your Recent History

Delayed Upgrade Clock